Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in JAK2V617F Positive Polycythemia Vera
NCT01901432Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Oct 2013
- Primary completion
- Jun 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of givinostat in polycythemia vera (PV), sponsored by Italfarmaco. Started Oct 2013; status: completed.
02
Drugs
givinostat
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT01901432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901432.